# Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis

Study · id `cardio:ct-nct04843072` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04843072](<https://clinicaltrials.gov/study/NCT04843072>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04843072

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT04843072. Randomized; no masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT04843072, source copy `cardio:ctgov-nct04843072-2026-10-13`, retrieved 2026-10-26)
- Started: 2021-05-01 (actual) (ClinicalTrials.gov record NCT04843072, source copy `cardio:ctgov-nct04843072-2026-10-13`, retrieved 2026-10-26)
- Primary completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT04843072, source copy `cardio:ctgov-nct04843072-2026-10-13`, retrieved 2026-10-26)
- Completion: 2029-05-01 (anticipated) (ClinicalTrials.gov record NCT04843072, source copy `cardio:ctgov-nct04843072-2026-10-13`, retrieved 2026-10-26)
- Countries: United States; Austria; Canada; Denmark; France; Germany; Greece; Italy; Netherlands; Portugal; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04843072, source copy `cardio:ctgov-nct04843072-2026-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04843072-2026-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
- Acronym: BASELINE
- Condition: Valve Heart Disease
- Intervention (Device): EVOLUT R/PRO/PRO+/FX bioprosthesis
- Intervention (Device): Edwards Sapien S3/Ultra bioprosthesis
- Intervention (Device): MYVAL/Octacor/Octapro bioprosthesis
- Lead sponsor: Erasmus Medical Center
- Lead sponsor class: OTHER
- Collaborator: Cedars-Sinai Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Erasmus Medical Center (`cardio:org-erasmus-medical-center`)
- Registry lists this organization as a collaborator: Cedars-Sinai Medical Center (`cardio:org-cedars-sinai-medical-center`)

## Provenance

Content hash: 9eaa2a18972c675400005ef77ab07194dbd9b9308bb0ac31b5618903c3cae88a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
